Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02948036 · ClinicalTrials.gov registry record · NA
A Closed-loop Assessment and Treatment Platform for Unipolar Depression and Anxiety
A NA study, sponsored by Posit Science Corporation.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT02948036 is a NA study that has completed, run by Posit Science Corporation. The registered enrollment target is 31 participants.
The verdict
NCT02948036, a NA study, has completed, sponsored by Posit Science Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Specific Aim 1: Finalize development of the closed-loop strategy in the MMT application. Specific Aim 2: Evaluate the acceptability and feasibility of the MMT application with the target population to prepare for a large-scale efficacy trial.
Interventions
- OTHER Mobile-device, plasticity-based adaptive cognitive treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2023-05-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02948036
The ClinicalTrials.gov registry entry for NCT02948036 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Posit Science Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mobile-device, plasticity-based adaptive cognitive treatment is the first listed.
NCT02948036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02948036 about?
NCT02948036 is a clinical study titled "A Closed-loop Assessment and Treatment Platform for Unipolar Depression and Anxiety". Specific Aim 1: Finalize development of the closed-loop strategy in the MMT application. Specific Aim 2: Evaluate the acceptability and feasibility of the MMT application with the target population to prepare for a large-scale efficacy trial.
What is the current status of trial NCT02948036?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2017-10-01. Estimated completion is 2023-05-11.
What interventions are being tested in trial NCT02948036?
The interventions under investigation include: Mobile-device, plasticity-based adaptive cognitive treatment (OTHER).
Who is sponsoring clinical trial NCT02948036?
This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.